Scarica l'app Stockscreener
27.88
2.42%
-0.69
Dopo l'orario di chiusura:
27.50
-0.38
-1.36%
Vera Therapeutics Inc Borsa (VERA) Ultime notizie
Vera Therapeutics, Inc. (VERA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Five new hires at Vera Therapeutics received share options and awards that vest over four years. - Stock Titan
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - globenewswire.com
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Vera Therapeutics (NASDAQ: VERA) CEO exercises options and sells shares under preset trading plan - Stock Titan
Vera Therapeutics CFO Young Joseph R Exercises 5,000 Stock Options at $3.94 (NASDAQ: VERA) - Kalkine Media
Vera Therapeutics (VERA) finance SVP adds 5,000 shares - Stock Titan
Vera Therapeutics at Cantor Fitzgerald conference: launch gains traction By Investing.com - Investing.com Canada
Vera Therapeutics at Cantor Fitzgerald conference: launch gains traction By Investing.com - Investing.com India
Centrus Announces Proposed Public Underwritten Offering of Class A Common Stock and Warrants - Yahoo Finance
Vera Therapeutics CEO Marshall Fordyce Executes 18,500 Share Sale Under 10b5-1 Trading Plan - Kalkine Media
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Discipline and Rules-Based Execution in VERA Response - Stock Traders Daily
Vera Therapeutics (NASDAQ: VERA) insider to sell tens of thousands of shares - Stock Titan
Vera Therapeutics stock gains after fresh analyst support - ad-hoc-news.de
Vera Therapeutics to Participate at Upcoming Investor Conferences - manilatimes.net
Vera Therapeutics to Participate at Upcoming Investor Conferences - GlobeNewswire
Vera Therapeutics to Participate at Upcoming Investor Conferences - Yahoo Finance
Vera Therapeutics options activity points to institutional bullish call spread on September strikes - investing.com
Nancy Lee Boman Net Worth (2026) - GuruFocus
Vera Therapeutics (NASDAQ:VERA): What Could Drive the Next Move? - Kalkine Media
What Vera Therapeutics (VERA)'s Widening Losses and Cash Burn Mean For Shareholders - Sahm
Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
H.C. Wainwright Maintains Vera Therapeutics(VERA.US) With Buy Rating, Cuts Target Price to $90 - Moomoo
What Vera Therapeutics (VERA)'s Widening Losses and Cash Burn Mean For Shareholders - simplywall.st
Bank of America Corp DE Has $23.72 Million Stake in Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics upgraded to Buy after FDA nod for TRUTAKNA and positive kidney function data. - Pluang
Vera Therapeutics: FDA's eGFR Analysis Supports A Speculative Buy (NASDAQ:VERA) - Seeking Alpha
Wedbush Reiterates Neutral Rating for Vera Therapeutics (NASDAQ:VERA) - MarketBeat
J.P. Morgan Maintains Vera Therapeutics(VERA.US) With Buy Rating, Cuts Target Price to $76 - Moomoo
Vera Therapeutics Stock (VERA) Opinions on Positive eGFR Data Release - Quiver Quantitative
Vera Therapeutics Shares Up 9.7% as $425,000 Drug Launch Puts Focus on Cash Reserves - TechStock²
Vera Therapeutics Climbs as Investors React to TRUTAKNA Launch Progress and Near-Term IgAN Milestones - Quiver Quantitative
Kynam Capital (VERA) now holds 4.01% beneficial stake in Vera Therapeutics - Stock Titan
Vera Therapeutics (NASDAQ:VERA) Shares Gap UpHere's Why - MarketBeat
HC Wainwright Has Positive Estimate for VERA Q3 Earnings - MarketBeat
Vera stock rises on FDA review for kidney drug (VERA:NASDAQ) - Seeking Alpha
Is Vera Therapeutics (VERA) Undervalued On FDA Approval For TRUTAKNA? - Sahm
(VERA) Volatility Zones as Tactical Triggers - Stock Traders Daily
Vera Therapeutics president and CEO Marshall Fordyce sells $701,769 in stock - Investing.com
Vera Therapeutics president and CEO Marshall Fordyce sells $1.96m in stock - Investing.com
Vera Therapeutics CEO Marshall Fordyce sells $679,747 in stock - investing.com
Vera Therapeutics president and CEO Marshall Fordyce sells $1.96m in stock - Investing.com Nigeria
Vera Therapeutics president and CEO Marshall Fordyce sells $701,769 in stock - Investing.com Canada
Vera Therapeutics president and CEO Marshall Fordyce sells $1.96m in stock - Investing.com South Africa
Vera Therapeutics president and CEO Marshall Fordyce sells $701,769 in stock - Investing.com South Africa
Vera Therapeutics president and CEO Marshall Fordyce sells $1.96m in stock - Investing.com India
Vera Therapeutics president and CEO Marshall Fordyce sells $701,769 in stock - Investing.com Australia
Vera Therapeutics president and CEO Marshall Fordyce sells $701,769 in stock - Investing.com India
Vera Therapeutics CEO Marshall Fordyce sells $679,747 in stock - Investing.com
11.99%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):